Objective To evaluate the efficacy of asarone injection in treating respiratory disease. Methods All the randomized controlled trials (RCTs) about treating respiratory disease with asarone injection were collected by searching MEDLINE (1990 to 2010), EMbase (1990 to 2010), CSJD (1989 to January 2010) and CNKI (1979 to December 2009). The assessment of methodological quality and data extraction of the included studies were performed independently by two reviewers, and Meta-analysis was conducted with RevMan 5.0 software. Results A total of 29 studies involving 3 931 patients met the inclusion criteria. The results of Meta-analysis showed that: a) Asarone injection was effective in treating respiratory diseases including bronchiolitis, chronic obstructive pulmonary diseases (COPD) and AECOPD, bronchitis and pneumonia; b) In treating bronchiolitis, asarone injection was superior to aminophylline, heartleaf houttuynia herb and virazole in total effective rate, and was similar to andrographolide in curative effect; c) In treating COPD and AECOPD, asarone injection was superior to symptomatic treatment and bromhexine in total effective rate, was similar to benzylpenicillin sodium and tablete glycyrrhiza in curative effect, and was inferior to aminophylline in total effective rate without significant difference; d) In treating bronchitis, asarone injection was superior to aminophylline and symptomatic treatment in total effective rate, and was similar to mucosolvin in curative effect; and e) In treating pneumonia, asarone injection was superior to antibiotic, ribavirin and aminophylline in total effective rate. Conclusion Asarone injection is effective in treating respiratory disease. Because of the lower methodological quality and publication bias of the included trials, it is necessary to perform more high-quality and large-scale randomized controlled trials to make the conclusion more reliable.
ObjectiveTo investigate the disease spectrum and cost constitution of patients aged over 65 years with respiratory diseases in Sichuan Provincial People's Hospital from 2010 to 2014. MethodsThe inpatients' clinical data and costs were collected from hospital information system. The diseases were classified and the cost constitution were analyzed. The data were analyzed using SPSS 18.0 software. ResultsThe total number of the inpatients aged over 65 years was 17600 from 2010 to 2014, with more males (64.0%) than females (36.0%). The patients aged 76.9 years on average and were mainly in the 65-89 age group which accounted for 94.4%. The patients were mainly distributed in geriatric department, respiratory department and emergency department, accounting for 78.2% of the total. The top three respiratory diseases were pneumonia, chronic obstructive pulmonary disease (COPD) and pulmonary tumor accounting for 86.5% of the total with more males than females. There was an upward trend in the proportion of pulmonary tumor, bronchiectasis and pulmonary tuberculosis, and a downward trend in the proportion of asthma, COPD and pneumothorax. The average length of hospital stay decreased from 17.6 days to 16.0 days since 2010, and the average cost per capita increased from ￥20162.6 yuan to ￥30015.1 yuan since 2010. The proportion of drug cost to inpatients hospitalization cost decreased from 57.2% to 48.8% since 2010. ConclusionsPneumonia, COPD and pulmonary tumor are main respiratory diseases of inpatients over 65 years in Sichuan Provincial People's Hospital from 2010 to 2014. The male inpatients are more than female inpatients. The incidence of pulmonary tumor and pulmonary tuberculosis rises, and of asthma and COPD goes down. The incidence of lung tumor is increasing in younger age groups. The average length of hospital stay and the proportion of drug cost have declined in recent five years, while the average cost per capita has increased.
Objective To investigate constitution and costs of inpatients with respiratory disease in the Karamay Central Hospital in 2014 and provide baseline data for further evidence-based study. Methods The information of drug use and expenditure of respiratory diseases were collected from the Hospital Information System (HIS). We analyzed the data by Microsoft Excel 2007 software, including the frequency, proportion and cumulative proportion. Results ① A total of 3 306 inpatients with respiratory disease were included, the top three diseases were bronchopneumonia, pneumonia and pulmonary infection, respectively. ② The Han-other people ratio in inpatients with respiratory diseases higher than average ratio in this city, the top three were bronchial asthma (non-severe) (40.21%), bronchopneumonia (38.14%) and acute exacerbation of chronic obstructive pulmonary disease (COPD) (36.27%), respectively. ③ The top three hospital stay and costs per capita were pulmonary infection, COPD and bronchial asthma (non-severe), respectively. Conclusion Bronchopneumonia, pulmonary infection, bronchial asthma and COPD are selected as the priority for evidence-based study.
ObjectivesTo investigate the prevalence of respiratory diseases and lung function of school-age children in Chongqing and to compare them with that of children in 25 years ago and to explore the possible causes of this change.MethodsAccording to the air quality data of Chongqing from 1998 to 2016, the annual variation of air quality days and pollutant concentrations were plotted. 2 126 school-age children in two districts of Chongqing were selected by random cluster sampling for questionnaires. 771 children were randomly selected from the children who completed the questionnaire for pulmonary function tests. The results were compared with that of 25 years ago.ResultsFrom 1998 to 2016, the number of days with good air quality in Chongqing increased annually, and the concentration of SO2 decreased significantly. The main air pollution composition changed from SO2 to PM10 and PM2.5. The prevalence of bronchitis (P<0.05) was higher than that of 25 years ago. After adjusting for confounding factors by multivariate logistic regression, the OR value of bronchitis in children was 1.667 (P<0.05) compared with 25 years ago. After adjusting for age, sex, height and weight by multiple linear regression, the results showed that the subjects' lung function indexes (FVC, FEV1, PEF and FEV3) were lower than that of 25 years ago. In this survey, there were differences in lung function indexes between children with different frequency of eating fruits and dairy products (P<0.05), and those with high frequency consumption were higher than low frequency. In terms of exercise time, subjects exercising ≥1 hour/day had greater FVC and FEV3 values than those exercising <1 hour/day (P<0.05).ConclusionsThe overall air quality in Chongqing has improved from 1998 to 2016; The respiratory health of children has decreased when compared with that of 25 years ago. Changes in the composition of air pollutants may endanger children's respiratory health, and fruit and dairy foods and exercise may be protective factors for children's respiratory health.
ObjectivesTo assess the methodological quality of Chinese clinical practice guidelines (CPGs) for respiratory diseases published in 2017, so as to provide evidence for developing and updating CPGs of this field in the future.MethodsWanFang Data, CNKI, VIP, CBM databases, Medlive and other related websites were electronically searched to collect Chinese CPGs for respiratory diseases published from January 2017 to December 2017. Four reviewers independently evaluated the quality of eligible guidelines by using Appraisal of Guidelines for Research and Evaluation Ⅱ (AGREE Ⅱ) instrument.ResultsA total of 37 guidelines were included. The mean scores of the six AGREE Ⅱ domains (scope and purpose, stakeholder involvement, rigor of development, clarity and presentation, applicability, editorial independence) were 59.3%, 25.1%, 10.8%, 59.1%, 25.8%, and 7.3%, respectively. Only 1 guideline (2.7%) was recommended for clinical use, and 2 guidelines (5.4%) were recommended with modification.ConclusionsThe CPGs for respiratory diseases published in China in 2017 have higher quality than CPGs published prior to 2017, however great discrepancies exist when comparing with international guidelines of average level. More attention should be paid on the rigorousness of methodology and the practicality of content in the future development of CPGs.